Hu Xiaojun, Ogawa Kazuma, Kiwada Tatsuto, Odani Akira
Division of Pharmaceutical Sciences, Graduate School of Medical Science, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa 920-1192, Japan.
Institute for Frontier Science Initiative, Kanazawa University, Kanazawa 920-1192, Japan.
J Inorg Biochem. 2017 May;170:1-7. doi: 10.1016/j.jinorgbio.2017.02.001. Epub 2017 Feb 4.
To develop a water-soluble and tumor-targeted photosensitizer for photodynamic therapy (PDT), a porphyrin framework containing the metal ion gallium(III) was combined with platinum(II)-based groups to produce two new pentacationic metalloporphyrinates, Ga-4cisPtTPyP (5,10,15,20-tetrakis{cis-diammine-chloro-platinum(II)}(4-pyridyl)-porphyrinato gallium(III) hydroxide tetranitrate) and Ga-4transPtTPyP (5,10,15,20-tetrakis{trans-diammine-chloro-platinum(II)} (4-pyridyl)-porphyrinato gallium(III) hydroxide tetranitrate). Both complexes exhibited high singlet oxygen quantum yields (Φ) and remarkable photocytotoxicity with appreciable phototoxic indexes (PIs). In particular, Ga-4cisPtTPyP showed a low IC value (Colon 26: 0.12μM; Sarcoma 180: 0.08μM) under illumination and its PI up to 1000. With outstanding tumor accumulation (tumor/muscle ratio>9), Ga-4cisPtTPyP almost completely inhibited tumor growth over two weeks in an in vivo PDT assay. These results imply that Ga-4cisPtTPyP could be a promising anticancer agent for use in PDT.
为开发一种用于光动力疗法(PDT)的水溶性且肿瘤靶向的光敏剂,将含有金属离子镓(III)的卟啉框架与铂(II)基基团结合,制备了两种新的五价金属卟啉盐,即Ga-4cisPtTPyP(5,10,15,20-四{顺式二胺氯铂(II)}(4-吡啶基)卟啉合镓(III)氢氧化物四硝酸盐)和Ga-4transPtTPyP(5,10,15,20-四{反式二胺氯铂(II)}(4-吡啶基)卟啉合镓(III)氢氧化物四硝酸盐)。两种配合物均表现出高的单线态氧量子产率(Φ)以及具有可观光毒性指数(PI)的显著光细胞毒性。特别地,Ga-4cisPtTPyP在光照下显示出低的IC值(结肠26:0.12μM;肉瘤180:0.08μM),其PI高达1000。凭借出色的肿瘤蓄积(肿瘤/肌肉比率>9),在体内PDT试验中,Ga-4cisPtTPyP在两周内几乎完全抑制了肿瘤生长。这些结果表明,Ga-4cisPtTPyP可能是一种用于PDT的有前景的抗癌剂。